org placeholder image

Chris Desimone

Director, Payer Access, Cell Therapy at Iovance Biotherapeutics

  • LinkedIn
map
IOVANCE BIOTHERAPEUTICS

IOVANCE BIOTHERAPEUTICS

  • Employees count Employees 501-1000
  • Revenue Revenue 100 Million to 250 Million
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Iovance Biotherapeutics Org Chart and Mapping

Employees

Lekisha Tucker

Sr. Clinical Data Manager

Jaqulyn Gamble

Quality Control Specialist

Marietta Flynn

Senior Director, Revenue

Tim Logan

VP, Global Commercial Operations

Amy Pagliarulo

Senior Director Atc Cell Therapy Operations

Jessie Jiang

Executive Director of Market Access Strategy and Operations

Leslie Kerns

Associate Director Authorized Treatment Center Cell Therapy Operations

Emily Cicalese

Information Technology Business Operations Analyst

Binh Truong

Executive Director, Regulatory Affairs Cmc

Frequently Asked Questions Regarding Chris Desimone

Answer: Chris Desimone works for Iovance Biotherapeutics as Director, Payer Access, Cell Therapy

Answer: Chris Desimone’s role in Iovance Biotherapeutics is Director, Payer Access, Cell Therapy

Answer: Chris Desimone's email address is c***@gmail.com

Answer: Chris Desimone's business email address is c****@sierraoncology.com

Answer: Chris Desimone’s direct phone number is (***)-***-****

Answer: Chris Desimone works in the industry of: Biotechnology

Answer: Chris Desimone works Iovance Biotherapeutics located at 825 Industrial Rd Ste 400, San Carlos, California, 94070, United States

Answer: Iovance Biotherapeutics's Director, Payer Access, Cell Therapy is Chris Desimone

Answer: Chris Desimone contact details:

  • Phone number  :  (***)-***-****
  • Email  :  c****@sierraoncology.com

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access